We are live on
!
Find out more
Oragenics
OGEN
OGEN
11 hedge funds and large institutions have $2.48M invested in Oragenics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
8% more capital invested
Capital invested by funds: $2.29M → $2.48M (+$186K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.01% less ownership
Funds ownership: 0.01% → 0.01% (-0.01%)
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$768K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$133K |
| 3 |
VF
Virtu Financial
New York
|
+$114K |
| 4 |
Barclays
London,
United Kingdom
|
+$72.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.96K |
Top Sellers
| 1 |
MP
MSD Partners
New York
|
-$49K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$41.2K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$35K |